Define Ventures’ Lynne Chou O’Keefe and Kleiner Perkins’ Annie Case
Lynne hopes MedArrive "will bring humanity to heath care in the home" while Annie believes "MedArrive’s partnership-driven approach will help them emerge as a leader in the space.”
Define Ventures’ Lynne Chou O’Keefe and Kleiner Perkins’ Annie Case back a company co-founded by Inna Plumb that Lynne tells Women’s PE Briefs she hopes “will bring humanity to health care in the home.” Define and Kleiner Perkins co-led MedArrive’s $4.5 million seed round.
Based in San Francisco, MedArrive enables health care providers and payors to extend services into the home. The company is focused on bridging the virtual care gap by integrating physician-led telemedicine with hands-on care from a network of emergency medical service professionals, such as EMTs and paramedics. MedArrive’s platform enables these professionals to leverage the full scope of their training, earn supplemental income and diversify their day-to-day responsibilities. Patients, in turn, are able to access medical expertise from the safety of their homes and within their existing health systems. By doing so, the company aims to improve patient outcomes, deploy a better utilized health care workforce and generate cost savings for patients and providers. The company will initially focus on Florida.
Inna, who is chief operating officer, founded MedArrive with Dan Trigub, who is CEO. Inna’s background includes co-founding Ever/Body, serving as a partner of Redesign Health, being a director of Dia & Co. and holding several roles with Blue Apron. Lynne said that Define believes “that continuity of care from hospital to home is a core strategy for health care even pre-COVID. With COVID, these services are even more essential and telemedicine cannot address all our needs in the health care system; we need health care services delivered to the home as well.”
Lynne, who formed Define after leaving Kleiner Perkins, said both her firm and Kleiner Perkins were looking at the deal separately and ultimately decided to co-lead and partner together. In a statement, Annie said that while “telemedicine is the clearest example of the pandemic remaking business as usual,” it “alone is not the answer.” There is, she added, a need for platforms like MedArrive “that can enrich and expand the use cases of telemedicine through onsite visits, and we believe MedArrive’s partnership-driven approach will help them emerge as a leader in the space.” In conjunction with the financing, Lynne and Annie joined MedArrive’s board.
Define also just backed Centivo, a digital health plan and Story Health, which is building virtualized specialty care solutions. (See Dish on the Deal). Earlier this year, Lynne backed Tia, Inc., a women’s health care platform founded by Carolyn Witte and Felicity Yost. She also has a portfolio company, Hims & Hers, set to go public through a merger with a special purpose acquisition company. Define closed its debut fund earlier this year at $65 million.
Other companies that Define has backed include Lightship, which provides enterprise level, direct-to-patient clinical research solutions; Verana Health, which is producing specialty clinical data; Unite Us, a social determinates of health platform coordinating care networks of health and community service providers; and Cohere Health, a value-based care platform for payers, providers and consumers.
Lynne is also a past speaker at the Women’s Private Equity Summit and will speak at the Virtual Women’s Alternative Investment Summit event in January.
Annie, a principal, is also involved with the boards of Future, Inkitt and Modern Health. Annie joined Kleiner Perkins last year from Uber where she was previously manager, strategy and planning.